Return to Statistics Toolbox

Volcano Plot analysis for Study ST003484

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells (3)
Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells (3)
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Group by metabolite classification:    Use:
Maximum # of (most significant) metabolites per class to use in pvalue group calculation:
Analysis:Combine data for all analyses?:     

  logo